Michael A. Catalano

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial

Charles J. Fisher, Gus J. Slotman, Steven M. Opal et al. · Critical Care Medicine · 1994 · 488 citations

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

Eric V. Granowitz, Reuven Porat, James W. Mier et al. · Cytokine · 1992 · 219 citations

Inflammation, Cytokine, Immunomodulatory Effects +10

Radioimmunoassay of IgG and IgM Rheumatoid Factors Reacting with Human IgG

Dennis A. Carson, Simon K. Lawrance, Michael A. Catalano et al. · The Journal of Immunology · 1977 · 139 citations

Immunology, Pathology, Immunotherapy +17

Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.

Michael A. Catalano, Dennis A. Carson, Susan F. Slovin et al. · Proceedings of the National Academy of Sciences · 1979 · 102 citations · Full text

Humoral Response, Immunology, Pathology +19

Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man.

Tom van der Poll, Kimberly J. Van Zee, Erik Endert et al. · The Journal of Clinical Endocrinology & Metabolism · 1995 · 81 citations

Inflammation, Il-1 Receptor Antagonist, Endotoxin Injection +13